167 related articles for article (PubMed ID: 22431073)
1. Prevalence of symptoms in female Fabry disease patients: a case-control survey.
Bouwman MG; Rombach SM; Schenk E; Sweeb A; Wijburg FA; Hollak CE; Linthorst GE
J Inherit Metab Dis; 2012 Sep; 35(5):891-8. PubMed ID: 22431073
[TBL] [Abstract][Full Text] [Related]
2. Musculoskeletal manifestations of Fabry disease: A retrospective study.
Lidove O; Zeller V; Chicheportiche V; Meyssonnier V; Sené T; Godot S; Ziza JM
Joint Bone Spine; 2016 Jul; 83(4):421-6. PubMed ID: 26697993
[TBL] [Abstract][Full Text] [Related]
3. The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
Mallett A; Kearey P; Cameron A; Healy H; Denaro C; Thomas M; Lee VW; Stark S; Fuller M; Hoy WE
BMC Nephrol; 2020 Feb; 21(1):58. PubMed ID: 32087678
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondents.
Berry L; Walter J; Johnson J; Alton J; Powers J; Llòria X; Koulinska I; McGee M; Laney D
Orphanet J Rare Dis; 2024 Apr; 19(1):153. PubMed ID: 38605390
[TBL] [Abstract][Full Text] [Related]
5. Fabry disease in children: a federal screening programme in Russia.
Namazova-Baranova LS; Baranov AA; Pushkov AA; Savostyanov KV
Eur J Pediatr; 2017 Oct; 176(10):1385-1391. PubMed ID: 28871487
[TBL] [Abstract][Full Text] [Related]
6. Absence of α-galactosidase cross-correction in Fabry heterozygote cultured skin fibroblasts.
Fuller M; Mellett N; Hein LK; Brooks DA; Meikle PJ
Mol Genet Metab; 2015 Feb; 114(2):268-73. PubMed ID: 25468650
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study.
Jahan S; Sarathchandran S; Akhter S; Goldblatt J; Stark S; Crawford D; Mallett A; Thomas M
Orphanet J Rare Dis; 2020 Jan; 15(1):10. PubMed ID: 31931840
[TBL] [Abstract][Full Text] [Related]
8. Natural history of Fabry disease in females in the Fabry Outcome Survey.
Deegan PB; Baehner AF; Barba Romero MA; Hughes DA; Kampmann C; Beck M;
J Med Genet; 2006 Apr; 43(4):347-52. PubMed ID: 16227523
[TBL] [Abstract][Full Text] [Related]
9. Demographic characterization of Brazilian patients enrolled in the Fabry Registry.
Martins AM; Kyosen SO; Garrote J; Marques FM; Guilhem JG; Macedo E; Sobral Neto J; Ura S
Genet Mol Res; 2013 Jan; 12(1):136-42. PubMed ID: 23408399
[TBL] [Abstract][Full Text] [Related]
10. Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry Disease.
Hamed A; DasMahapatra P; Lyn N; Gwaltney C; Hopkin RJ
Orphanet J Rare Dis; 2021 Jun; 16(1):285. PubMed ID: 34172077
[TBL] [Abstract][Full Text] [Related]
11. Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient Survey.
Morand O; Johnson J; Walter J; Atkinson L; Kline G; Frey A; Politei J; Schiffmann R
Adv Ther; 2019 Oct; 36(10):2866-2880. PubMed ID: 31435831
[TBL] [Abstract][Full Text] [Related]
12. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.
Wilcox WR; Oliveira JP; Hopkin RJ; Ortiz A; Banikazemi M; Feldt-Rasmussen U; Sims K; Waldek S; Pastores GM; Lee P; Eng CM; Marodi L; Stanford KE; Breunig F; Wanner C; Warnock DG; Lemay RM; Germain DP;
Mol Genet Metab; 2008 Feb; 93(2):112-28. PubMed ID: 18037317
[TBL] [Abstract][Full Text] [Related]
13. Social-adaptive and psychological functioning of patients affected by Fabry disease.
Laney DA; Gruskin DJ; Fernhoff PM; Cubells JF; Ousley OY; Hipp H; Mehta AJ
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S73-81. PubMed ID: 20087663
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey.
Huzmeli C; Candan F; Alaygut D; Bagci G; Akkaya L; Bagci B; Sozmen EY; Kurtulgan HK; Kayatas M
Biochem Genet; 2016 Aug; 54(4):448-456. PubMed ID: 27105876
[TBL] [Abstract][Full Text] [Related]
15. Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ).
Ramaswami U; Stull DE; Parini R; Pintos-Morell G; Whybra C; Kalkum G; Rohrbach M; Raluy-Callado M; Beck M; Chen WH; Wiklund I;
Health Qual Life Outcomes; 2012 Sep; 10():116. PubMed ID: 22992222
[TBL] [Abstract][Full Text] [Related]
16. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
17. Genotype⁻Phenotype Correlation in a New Fabry-Disease-Causing Mutation.
Čerkauskaitė A; Čerkauskienė R; Miglinas M; Laurinavičius A; Ding C; Rolfs A; Vencevičienė L; Barysienė J; Kazėnaitė E; Sadauskienė E
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31067829
[No Abstract] [Full Text] [Related]
18. The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study.
Turkmen K; Guclu A; Sahin G; Kocyigit I; Demirtas L; Erdur FM; Sengül E; Ozkan O; Emre H; Turgut F; Unal H; Karaman M; Acıkel C; Esen H; Balli E; Bıtırgen G; Tonbul HZ; Yılmaz MI; Ortiz A
Kidney Blood Press Res; 2016; 41(6):1016-1024. PubMed ID: 28006774
[TBL] [Abstract][Full Text] [Related]
19. The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis.
Verrecchia E; Zampetti A; Antuzzi D; Ricci R; Ferri L; Morrone A; Feliciani C; Dagna L; Manna R
Eur J Intern Med; 2016 Jul; 32():26-30. PubMed ID: 27083555
[TBL] [Abstract][Full Text] [Related]
20. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.
Ries M; Ramaswami U; Parini R; Lindblad B; Whybra C; Willers I; Gal A; Beck M
Eur J Pediatr; 2003 Nov; 162(11):767-72. PubMed ID: 14505049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
